Viccilin - Pharmacology: Inhibits bacterial cell wall mucopeptide synthesis.
Indication: Treatment of respiratory, GI, and GU tract and soft tissue infections, bacterial meningitis and enterococcal endocarditis, septicemia and gonococcal infections caused by susceptible microorganisms.
Unlabeled Uses
Prophylaxis in Cesarean section in certain high risk patients.
Used for: Treating infections caused by certain types of bacteria.
Viccilin is a penicillin antibiotic. It works by killing sensitive bacteria by interfering with formation of the bacteria's cell wall while it is growing. This weakens the cell wall and it ruptures, resulting in the death of the bacteria.
Viccilin is an antibiotic in the penicillin group of drugs. It fights bacteria in your body.
Viccilin is used to treat many different types of infections caused by bacteria, such as ear infections, bladder infections, pneumonia, gonorrhea, and E. coli or salmonella infection.
Viccilin may also be used for purposes not listed in this medication guide.
Viccilin is an antibiotic of semisynthetic broad-spectrum penicillin group. This medication has a bactericidal effect by suppressing the synthesis of bacterial cell walls. Viccilin is active against aerobic gram-positive bacteria: Staphylococcus spp. (with the exception of strains producing penicillinase), Streptococcus spp., Enterococcus spp., Listeria monocytogenes; aerobic gram-negative bacteria: Neisseria gonorrhoeae, Neisseria meningitidis, Escherichia coli, Shigella spp., Salmonella spp., Bordetella pertussis, some strains of Haemophilus influenzae. Ampicillin destroyed by penicillinase. This drug is acid-resistant.
Viccilin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Viccilin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Viccilin results from the inhibition of cell wall synthesis and is mediated through Viccilin binding to penicillin binding proteins (PBPs). Viccilin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.
Ampicillin is one of the most widely prescribed antibiotics. It is considered a penicillin and is a close relative of another penicillin, amoxicillin. Unlike penicillin, Viccilin and amoxicillin can penetrate and prevent the growth of certain types of bacteria, called gram-negative bacteria.
Indications: tell your doctor and pharmacist if you are allergic to ampicillin, penicillin, or any other drugs. tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially other antibiotics, allopurinol (Lopurin), anticoagulants ('blood thinners') such as warfarin (Coumadin), atenolol (Tenormin), oral contraceptives, probenecid (Benemid), rifampin, sulfasalazine, and vitamins. tell your doctor if you have or have ever had kidney or liver disease, allergies, asthma, blood disease, colitis, stomach problems, or hay fever. tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking ampicillin, call your doctor. if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking ampicillin.
Viccilin is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin belongs to a group of antibiotics called the penicillins.
Oral Biliary tract infections
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Endocarditis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Otitis media
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Peritonitis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Bronchitis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Perinatal streptococcal infections
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Gastroenteritis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Listeriosis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Susceptible infections
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Typhoid and paratyphoid fever
Adult: 1-2 g every 6 hr for 2 wk in acute infections and 4-12 wk in carriers. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. Oral Uncomplicated gonorrhoea
Adult: 2 g with 1 g of probenecid as a single dose, recommended to be repeated in female patients. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Intravenous Intrapartum prophylaxis against group B Streptoccocal infection in neonates
Adult: Initially, 2 g via inj followed by 1 g every 4 hr until delivery. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Injection As supplement in systemic therapy for treatment of susceptible infections
Adult: For intrapleural or intraperitoneal injections: 500 mg daily, dissolved in 5-10 ml of water. For intra-articular inj: 500 mg daily, dissolved in up to 5 ml of water or a solution of 0.5% procaine HCl.
Child: ½ the adult dose. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Parenteral Meningitis
Adult: 150-200 mg/kg daily in equally divided doses every 3-4 hr. May initiate with IV admin followed by IM injections.
Child: and infants: 150 mg/kg daily in divided doses. Neonates: <1 wk: 50 mg/kg every 12 hr; older neonates: 50 mg/kg every 8 hr. Max: 3 g/day. May initiate with IV admin followed by IM injections. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Intravenous Septicaemia
Adult: 150-200 mg/kg daily. Initiate with IV admin for at least 3 days, then continue with IM inj every 3-4 hr. Continue treatment for at least 48-72 hr after the patient has become asymptomatic or when there is evidence of bacterial eradication. Recommended treatment duration for infections caused by group-A β-haemolytic streptococci: At least 10-days to prevent occurrence of acute rheumatic fever or acute glomerulonephritis. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Parenteral Susceptible infections
Adult: 250-500 mg every 6 hr, can be given via IM or slow IV inj over 3-5 minutes or infusion.
Child: 100-400 mg/kg daily in divided doses every 6 hr. Max: 12 g daily. Dose can be given via IM or slow IV inj over 3-5 minutes or infusion. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Reconstitution: Reconstitute according to manufacturer's instructions. See lit. Incompatibility: Y-site incompatibility: Amphotericin B cholesteryl sulfate complex, ondansetron, sargramostim, verapamil, vinorelbine epinephrine, fluconazole, hydralazine, midazolam. Syringe incompatibility: Erythromycin lactobionate, gentamicin, lincomycin, metoclopramide, hydromorphone, kanamycin. Admixture incompatibility: Amikacin, hydralazine, prochlorperazine, chlorpromazine, dopamine, gentamicin.
Viccilin (Tai Yu) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (Tai Yu) belongs to a group of antibiotics called the penicillins.
Viccilin (Kingdom) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (Kingdom) belongs to a group of antibiotics called the penicillins.
Viccilin (C.I.) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (C.I.) belongs to a group of antibiotics called the penicillins.
Viccilin (Chi Sheng) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (Chi Sheng) belongs to a group of antibiotics called the penicillins.
Viccilin (Gentle) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (Gentle) belongs to a group of antibiotics called the penicillins.
Viccilin (Y.C.) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (Y.C.) belongs to a group of antibiotics called the penicillins.
Viccilin (Prince) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (Prince) belongs to a group of antibiotics called the penicillins.
Viccilin (Astar) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (Astar) belongs to a group of antibiotics called the penicillins.
Oral Biliary tract infections
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Endocarditis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Otitis media
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Peritonitis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Bronchitis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Perinatal Streptococcal Infections
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Gastroenteritis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Listeriosis
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Susceptible infections
Adult: 250-500 mg every 6 hr.
Child: 50-100 mg/kg daily, given in equally divided doses every 6 hr. Max: 2-4 g/day. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Oral Typhoid and Paratyphoid Fever
Adult: 1-2 g every 6 hr for 2 wk in acute infections and 4-12 wk in carriers. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. Oral Uncomplicated gonorrhoea
Adult: 2 g with 1 g of probenecid as a single dose, recommended to be repeated in female patients. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Intravenous Intrapartum prophylaxis against group B Streptoccocal infection in neonates
Adult: Initially, 2 g via inj followed by 1 g every 4 hr until delivery. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Intravenous Septicaemia
Adult: 150-200 mg/kg daily. Initiate with IV admin for at least 3 days, then continue with IM inj every 3-4 hr. Continue treatment for at least 48-72 hr after the patient has become asymptomatic or when there is evidence of bacterial eradication. Recommended treatment duration for infections caused by group-A β-haemolytic streptococci: At least 10-days to prevent occurrence of acute rheumatic fever or acute glomerulonephritis. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Parenteral Meningitis
Adult: 150-200 mg/kg daily in equally divided doses every 3-4 hr. May initiate with IV admin followed by IM injections.
Child: and infants: 150 mg/kg daily in divided doses. Neonates: <1 wk: 50 mg/kg every 12 hr; older neonates: 50 mg/kg every 8 hr. Max: 3 g/day. May initiate with IV admin followed by IM injections. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Parenteral Susceptible infections
Adult: 250-500 mg every 6 hr, can be given via IM or slow IV inj over 3-5 minutes or infusion.
Child: 100-400 mg/kg daily in divided doses every 6 hr. Max: 12 g daily. Dose can be given via IM or slow IV inj over 3-5 minutes or infusion. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Injection As supplement in systemic therapy for treatment of susceptible infections
Adult: For intrapleural or intraperitoneal injections: 500 mg daily, dissolved in 5-10 ml of water. For intra-articular inj: 500 mg daily, dissolved in up to 5 ml of water or a solution of 0.5% procaine HCl.
Child: ½ the adult dose. Renal impairment: Patients undergoing haemodialysis should receive an additional dose after the session. CrCl (ml/min) Dosage Recommendation <10 Dose reduction or increase in dose interval. Reconstitution: Reconstitute according to manufacturer's instructions. Incompatibility: Y-site incompatibility: Amphotericin B cholesteryl sulfate complex, ondansetron, sargramostim, verapamil, vinorelbine epinephrine, fluconazole, hydralazine, midazolam. Syringe incompatibility: Erythromycin lactobionate, gentamicin, lincomycin, metoclopramide, hydromorphone, kanamycin. Admixture incompatibility: Amikacin, hydralazine, prochlorperazine, chlorpromazine, dopamine, gentamicin.
Viccilin (K.T) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (K.T) belongs to a group of antibiotics called the penicillins.
Viccilin (VPP) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Viccilin (VPP) belongs to a group of antibiotics called the penicillins.
It is
Used for:Bacterial infections of the ear, nose and throat, eg otitis media, sinusitis. Bronchitis. Pneumonia. Bacterial infections of the urinary tract. Gynaecological infections, eg gonorrhoea. Bacterial infection of the blood (septicaemia or blood poisoning).Bacterial infections in the abdomen (peritonitis).Bacterial infections of the stomach and intestines. Bacterial infection of the heart valves and the lining surrounding the heart (bacterial endocarditis).Bacterial meningitis. Typhoid and paratyphoid fever.
Viccilin is indicated in the treatment of the following infections due to susceptible organisms they include : biliary – tract infections, bronchitis, Endocarditi, epiglottitis, gastro–enteritis (E.coli enteritis, Salmonella enteritis, and shigellosis), gonorrhea, listeriosis, meningitis, otitis media, perinatal streptococcal infections intrapartum prophylaxis against group B streptococcus, peritonitis, pneumoniae, septicaemia, typhoid and paratyphoid fever, and urinary – tract infections. |
brand and generic drugs
